<DOC>
	<DOCNO>NCT01375452</DOCNO>
	<brief_summary>The purpose study compare bioavailability healthy , post menopausal woman subject fasting condition .</brief_summary>
	<brief_title>Bioavailability Study Letrozole Tablets 2.5 mg Dr.Reddy 's Under Fasting Conditions</brief_title>
	<detailed_description>An Open Label , Balanced , Randomized , Two Treatment , Two Sequence , Two Period , Cross-Over , Single-Dose , Comparative oral bioavailability study healthy , post menopausal woman subject fasting condition .</detailed_description>
	<mesh_term>Letrozole</mesh_term>
	<criteria>Healthy post menopausal woman within age range 40 69 year . A body mass index within 1829.9 Kg/m2 The postmenopausal status confirm Serum Estradiol concentration &lt; 40 pg/mL . Serum follicle stimulate hormone ( FSH ) concentration &gt; 30 IU/L . No vaginal bleeding least 1 year . Given write informed consent participate study . Absence disease marker HIV 1 &amp; 2 , hepatitis B &amp; C virus RPR . Absence significant disease clinically significant abnormal laboratory value laboratory evaluation , medical history physical examination screening . A normal 12lead ECG . A normal chest Xray ( PA view ) six month date dosing . Comprehension nature purpose study compliance requirement entire protocol . No history evidence hypersensitivity/idiosyncratic reaction Letrozole relate drug peanut product ingredient Letrozole formulation . No history significant systemic disease . Nonsmokers . No history psychiatric disorder . No donation blood ( one unit 350 mL ) within 56 day prior study check . No history addiction recreational drug drug dependence . No participation clinical study within past 56 day . No receipt prescription drug within 4 week overthecounter drug ( e.g . : Cold preparation , antacid preparation vitamins natural product use therapeutic benefit ) within 14 day prior receive first dose study medication repeat use drug within last four week . No history dehydration diarrhea , vomit reason within period 24 hour prior study checkin . No family history neurological disorder . Not consume alcohol xanthine contain food beverage , ( chocolate , tea , coffee cola drink ) cigarettes tobacco product , least 48 hour , prior study checkin . Not consumed grape fruit contain food beverage ( mosumbi/sweet lime ) poppy contain food within 7 day prior checkin period . Negative result drug abuse ( Benzodiazepines , Cocaines , Opioids , Amphetamines , Cannabinoids Barbiturates ) urine period study checkin . Negative alcohol breathe analysis period study checkin . The subject exclude base follow criterion . Subjects incapable understanding informed consent . History suggestive breast carcinoma , endometrial carcinoma cervical carcinoma . History suggestive deep vein thrombosis and/or undiagnosed vaginal bleeding . History thromboembolic disorder . History seizure . History major surgical procedure past 3 month . History diabetes mellitus systemic hypertension . Past history anaphylaxis angioedema . History porphyria , DubinJohnson , Rotor syndrome hyperbilirubinemia syndrome . History otosclerosis exacerbate pregnancy . History cardiovascular , renal , hepatic , ophthalmic , pulmonary , neurological , metabolic , hematological , gastrointestinal , endocrine immunological disease . Consumption alcohol two year , consumption three alcoholic drink per day consumption alcohol within 48 hour prior dose study { one drink equal one unit alcohol [ one glass wine , half pint beer , one measure ( one ounce ) spirit } . History difficulty donate blood difficulty accessibility vein . An unusual abnormal diet e.g . low sodium diet , two week prior receive medication subject 's participation study , whatever reason e.g . fast due religious reason . Any major illness past three month clinically significant ongoing chronic medical illness e.g . congestive heart failure , hepatitis , pancreatitis etc . If Dysplastic change Papanicolaou Smear . Female volunteer demonstrate positive pregnancy test . Female volunteer currently breastfeed . History problem swallow tablet . Used oral contraceptive containing estrogens progesterone , form hormonal therapy intake HRT pharmacological agent know significantly induce inhibit drug metabolize enzyme within 6 month start study . History habituation coffee , tea xanthine containing product inability withhold intake thein housestay .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>